Correlation Between Fidelity Advisor and Tekla Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Tekla Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Tekla Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity Advisor Freedom and Tekla Healthcare Opportunities, you can compare the effects of market volatilities on Fidelity Advisor and Tekla Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Tekla Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Tekla Healthcare.

Diversification Opportunities for Fidelity Advisor and Tekla Healthcare

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Fidelity and Tekla is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Freedom and Tekla Healthcare Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tekla Healthcare Opp and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Freedom are associated (or correlated) with Tekla Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tekla Healthcare Opp has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Tekla Healthcare go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Tekla Healthcare

Assuming the 90 days horizon Fidelity Advisor is expected to generate 1.9 times less return on investment than Tekla Healthcare. But when comparing it to its historical volatility, Fidelity Advisor Freedom is 2.58 times less risky than Tekla Healthcare. It trades about 0.04 of its potential returns per unit of risk. Tekla Healthcare Opportunities is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,671  in Tekla Healthcare Opportunities on October 4, 2024 and sell it today you would earn a total of  192.00  from holding Tekla Healthcare Opportunities or generate 11.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fidelity Advisor Freedom  vs.  Tekla Healthcare Opportunities

 Performance 
       Timeline  
Fidelity Advisor Freedom 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fidelity Advisor Freedom has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Tekla Healthcare Opp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Healthcare Opportunities has generated negative risk-adjusted returns adding no value to fund investors. Even with inconsistent performance in the last few months, the Fund's technical indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the fund retail investors.

Fidelity Advisor and Tekla Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity Advisor and Tekla Healthcare

The main advantage of trading using opposite Fidelity Advisor and Tekla Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Tekla Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will offset losses from the drop in Tekla Healthcare's long position.
The idea behind Fidelity Advisor Freedom and Tekla Healthcare Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance